Showing results (1141-1150 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|March 23, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
Drug Safety|March 8, 2025
Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?Lucinda Smith, Michael Glaser, Dieter Kempf, et al.
Drug Safety|March 13, 2025
Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative BlueprintMeredith Y Smith, Rachel Davis, Priya Bahri, et al.
Drug Safety|December 12, 2024
Prenatal and Early Childhood Exposure to Proton Pump Inhibitors and Antibiotics and the Risk of Childhood Cancer: A Nationwide Population-Based Cohort StudyUnnur Gudnadottir, Emma Fransson, Gustaf Ljungman, et al.
Drug Safety|November 8, 2024
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance DatabaseSara Ferraro, Emiliano Cappello, Marco Fornili, et al.
Drug Safety|September 26, 2024
An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney InjuryDaniel Fernández-Llaneza, Romy M P Vos, Joris E Lieverse, et al.
Drug Safety|September 12, 2024
Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart FailureMartin F Casey, Joy Hallmark, Patricia P Chang, et al.
Drug Safety|February 21, 2025
Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in SingaporeYen Ling Koon, Yan Tung Lam, Hui Xing Tan, et al.
Drug Safety|February 20, 2025
Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabelLeihong Wu, Hong Fang, Yanyan Qu, et al.
Drug Safety|August 19, 2024
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic ReviewRenato Ferreira-da-Silva, Joana Reis-Pardal, Manuela Pinto, et al.
Pageof 311